 Home > Active Ingredient News > Study of Nervous System > FDA shelved clinical plans to test lysergic acid diethylamine (LSD) for the treatment of generalized anxiety disorder (GAD)

FDA shelved clinical plans to test lysergic acid diethylamine (LSD) for the treatment of generalized anxiety disorder (GAD)

 Last Update: 2022-01-08
 Source: Internet
 Author: User

Tags

drug delivery system

women future

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Generalized Anxiety Disorder (GAD) is a state of constant anxiety about trivial matters.
This anxiety has nothing to do with any specific surroundings, but is generally caused by excessive worry
.

There are four symptoms of generalized anxiety disorder: motor tension, nervous system overactivity, worry about the future, fear, and excessive alertness

child

Figure 1.
The prevalence of GAD

Biopharmaceutical company Mind Medicine recently revealed that the FDA has shelved a Phase IIb trial of lysergic acid diethylamine (LSD) for the treatment of generalized anxiety disorder (GAD)
.

The reason for this move is not yet clear, but the company said it expects to provide more details within 30 days

Biopharmaceutical company Mind Medicine recently revealed that the FDA has shelved a Phase IIb trial of lysergic acid diethylamine (LSD) for the treatment of generalized anxiety disorder (GAD)

The frustration of psychedelic adjuvant therapy

This FDA move is the latest blow to the field of psychedelic adjuvant therapy
.

In November, due to safety issues with the experimental drug COMP360 of the pharmaceutical company COMPASS Pathways, the FDA held a negative attitude towards the drug

Original source:

https://firstwordpharma.

https://firstwordpharma.
com/story/5466469 https://firstwordpharma.
com/story/5466469 Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Pregabalin White powder CAS 148553-50-8 In Stock

CAS No.: 148553-50-8

Pharmacy Grade

$0.9/KG FOB

Pregabalin High pure 99% up Pregabalin powder CAS 148553-50-8 for sale

CAS No.: 148553-50-8

Pharmacy Grade

$0.6/G FOB

Factory Price Enhancements Yohimbine Powder Yohimbine HCl CAS 65-19-0 Over 99% Purity

CAS No.: 65-19-0

Chemical Grade

$3.5-4/MT FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.